Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Ebiomedicine|February 1, 2026
Germline duplication of MYCN predisposes to childhood embryonal tumoursCatherine A Taylor, Philippa May, Thomas J Stone, et al.
International Journal of Cancer|December 12, 2018
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastomaLindi Chen, Fabio Pastorino, Philip Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2009
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastomaRachel A Daniel, Agata L Rozanska, Huw D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2019
Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic BiomarkersSwathi Merugu, Lindi Chen, Elizabeth Gavens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed NeuroblastomaJane Carr-Wilkinson, Kieran O'Toole, Katrina M Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumorsSean Carlin, Rob J Mairs, Anthony G McCluskey, et al.
Oncotarget|December 10, 2015
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastomaAnneleen Decock, Maté Ongenaert, Robrecht Cannoodt, et al.
British Journal of Cancer|November 8, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodologyRichard Phillips, Bristi Basu, Zohra Butt, et al.
Cancers|March 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Cancers|October 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Pageof 7